Virtus Biotech Clinical Trials ETF
 
 
 
 
基本資料
種類: ETF
費用比率%: 0.79
資產淨值: 42.98
成立日期: 16/12/2014
 
分析
市值分佈:
27.79%
大市值
37.89%
中市值
34.65%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 07/11/2026 05:47) 總持有投資項目: 132  
0%
 
100%
     10大 (16.14%)
代號 名稱 佔比% ▼ 持有日期
KODKodiak Sciences2.2630/10/2026
TRAXFirst Tracks Biotherapeutics Inc.1.9830/10/2026
XNCRXencor1.8830/10/2026
ABCLAbCellera Biologics1.8230/10/2026
REPLReplimune Group1.5430/10/2026
AMLXAmylyx Pharmaceuticals1.5330/10/2026
SGPSpyGlass Pharma Inc1.3630/10/2026
PRMEPrime Medicine1.3230/10/2026
VTYX--1.2627/02/2026
DICETema Trading & Prediction Markets ETF1.2331/07/2023
NRIXNurix Therapeutics1.2330/10/2026
MBXMBX Biosciences Inc.1.2230/10/2026
VRDNViridian Therapeutics1.1730/10/2026
DFTXDefinium Therapeutics Inc1.1430/10/2026
MANEVeradermics Inc1.1330/10/2026
ZBIOZenas Biopharma Inc.1.1130/10/2026
CNTA--1.1129/05/2026
LBRXLB Pharmaceuticals Inc1.0830/10/2026
ORKAOruka Therapeutics Inc1.0830/10/2026
VORVor Biopharma Inc1.0630/10/2026
 1    2    3    4    5    6    7  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.